240 related articles for article (PubMed ID: 24831092)
1. Editorial overview: vaccines against challenging viral pathogens and new vaccine technology.
Lu S
Curr Opin Virol; 2014 Jun; 6():viii-ix. PubMed ID: 24831092
[No Abstract] [Full Text] [Related]
2. Editorial overview.
Ertl H; Pulendran B
Curr Opin Virol; 2011 Oct; 1(4):223-5. PubMed ID: 22440780
[No Abstract] [Full Text] [Related]
3. Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challenges.
Rappuoli R; Sutter G
Curr Opin Virol; 2017 Apr; 23():vi-viii. PubMed ID: 28622999
[No Abstract] [Full Text] [Related]
4. Vaccines against dengue virus.
Woodland DL
Viral Immunol; 2015 Mar; 28(2):75. PubMed ID: 25689610
[No Abstract] [Full Text] [Related]
5. Editorial overview: Viral immunology.
Dittmer D; Damania B
Curr Opin Virol; 2020 Oct; 44():v-vi. PubMed ID: 33349419
[No Abstract] [Full Text] [Related]
6. [Immunity of viruses and the effectiveness of vaccines. Mode of virus infections and effectiveness of vaccines].
Shishido A
Nihon Rinsho; 1987 Oct; 45(10):2218-24. PubMed ID: 3448260
[No Abstract] [Full Text] [Related]
7. Editorial overview: Preventive and therapeutic vaccines (B cell epitope vaccine).
Law M
Curr Opin Virol; 2015 Apr; 11():viii-x. PubMed ID: 26003398
[No Abstract] [Full Text] [Related]
8. A focus on humoral immunity to viral infections.
Woodland DL
Viral Immunol; 2012 Dec; 25(6):441. PubMed ID: 23216306
[No Abstract] [Full Text] [Related]
9. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges.
Delrue I; Verzele D; Madder A; Nauwynck HJ
Expert Rev Vaccines; 2012 Jun; 11(6):695-719. PubMed ID: 22873127
[TBL] [Abstract][Full Text] [Related]
10. A focus on vaccination strategies.
Woodland DL
Viral Immunol; 2014 Nov; 27(9):421. PubMed ID: 25361209
[No Abstract] [Full Text] [Related]
11. Viruses - from pathogens to vaccine carriers.
Small JC; Ertl HC
Curr Opin Virol; 2011 Oct; 1(4):241-5. PubMed ID: 22003377
[TBL] [Abstract][Full Text] [Related]
12. Novel vaccine strategies against emerging viruses.
García-Sastre A; Mena I
Curr Opin Virol; 2013 Apr; 3(2):210-6. PubMed ID: 23477832
[TBL] [Abstract][Full Text] [Related]
13. Vaccine Development.
Woodland DL
Viral Immunol; 2017 Apr; 30(3):141. PubMed ID: 28281914
[No Abstract] [Full Text] [Related]
14. Viral vectors for use in the development of biodefense vaccines.
Lee JS; Hadjipanayis AG; Parker MD
Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875
[TBL] [Abstract][Full Text] [Related]
15. Editorial overview: Antiviral strategies.
Gale M; Horvath CM
Curr Opin Virol; 2015 Jun; 12():v-vii. PubMed ID: 26004174
[No Abstract] [Full Text] [Related]
16. Keystone conference on viral immunity: from basic mechanisms to vaccines (X7) and advances in influenza research: from birds to bench to bedside (X8) Steamboat Springs, Colorado March 28-April 2, 2006.
Liu F; Slifka MK
Viral Immunol; 2006; 19(3):584-9. PubMed ID: 16987078
[No Abstract] [Full Text] [Related]
17. Animal vaccination and the evolution of viral pathogens.
Schat KA; Baranowski E
Rev Sci Tech; 2007 Aug; 26(2):327-38. PubMed ID: 17892155
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic epitopes, heterologous immunity and vaccine design.
Welsh RM; Fujinami RS
Nat Rev Microbiol; 2007 Jul; 5(7):555-63. PubMed ID: 17558423
[TBL] [Abstract][Full Text] [Related]
19. Antibodies, viruses and vaccines.
Burton DR
Nat Rev Immunol; 2002 Sep; 2(9):706-13. PubMed ID: 12209139
[TBL] [Abstract][Full Text] [Related]
20. Specific immunoprophylaxis of some viral diseases in cattle.
Rola J; Polak MP; Zmudziński JF
Pol J Vet Sci; 2005; 8(4):315-21. PubMed ID: 16385857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
